Glycyrrhizin versus antiviral drugs for chronic hepatitis B virus infection

To evaluate the benefits and harms of glycyrrhizin preparations for patients with chronic HBV infection.

This is a protocol.

Health topics:

Published:

16 February 2011

Authors:

Xia Y, Liu JP, Gluud C

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Xia Y, Liu JP, Gluud C. Glycyrrhizin versus antiviral drugs for chronic hepatitis B virus infection. Cochrane Database of Systematic Reviews 2011, Issue 2. Art. No.: CD009003. DOI: 10.1002/14651858.CD009003